[1]韩乔木,宫丽鸿,吴启华,等.化痰祛瘀方对心房颤动大鼠血管细胞黏附分子-1及血管性血友病因子的影响[J].陕西中医,2022,(9):1180-1184.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.006]
　HAN Qiaomu,GONG Lihong,WU Qihua,et al.Effects of Huatan Quyu formula on rats with atrial fibrillation in serum VCAM-1 and vWF[J].,2022,(9):1180-1184.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.006]
点击复制

化痰祛瘀方对心房颤动大鼠血管细胞黏附分子-1及血管性血友病因子的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年9期
页码:
1180-1184
栏目:
基础研究
出版日期:
2022-09-05

文章信息/Info

Title:
Effects of Huatan Quyu formula on rats with atrial fibrillation in serum VCAM-1 and vWF
作者:
韩乔木1; 宫丽鸿2; 吴启华1; 史富羽1; 赵 帅1; 肖福龙2
(1.辽宁中医药大学,辽宁 沈阳 110847; 2.辽宁中医药大学附属医院,辽宁 沈阳 110032)
Author(s):
HAN Qiaomu; GONG Lihong; WU Qihua; SHI Fuyu; ZHAO Shuai; XIAO Fulong
(Liaoning University of Traditional Chinese Medicine,Shenyang 110847,China)
关键词:
心房颤动;  心悸;  化痰祛瘀方;  血管细胞黏附分子-1;  血管性血友病因子
Keywords:
Atrial fibrillation;  Xin Ji;  Huatan Quyu formula;  Vascular cell adhesion molecule-1;  Vascular hemophilia factor
分类号:
R 541.7
DOI:
DOI:10.3969/j.issn.1000-7369.2022.09.006
文献标志码:
A
摘要:
目的:探讨化痰祛瘀方对心房颤动大鼠的治疗作用及对血清中血管细胞黏附分子-1(VCAM-1)、血管性血友病因子(vWF)的影响。方法:将60只雄性SD大鼠随机分组,喂饲高脂饮食并注射乙酰胆碱氯化钙混合液制备房颤痰浊血瘀证大鼠模型。造模7 d后,连续灌胃化痰祛瘀方2周,观察各组大鼠房颤持续时间、透射电镜下心房肌细胞超微结构以及血清中VCAM-1、vWF水平。结果:中药高浓度组、中药中浓度组、中药低浓度组、维拉帕米组大鼠房颤持续时间均短于模型组,差异有统计学意义(均P<0.05)。透射电镜下,模型组大鼠心房肌细胞的肌小节断裂,心肌细胞肌丝溶解断裂,线粒体肿胀、增多,嵴断裂溶解,呈空泡样改变。中药中浓度组大鼠心房肌细胞的肌小节相对完整,肌丝稍模糊,线粒体肿胀,偶见线粒体溶解,结构相对完整。中药高浓度组、中药中浓度组大鼠血清VCAM-1浓度均低于模型组,差异有统计学意义(均P<0.05)。中药高浓度组、中药中浓度组、中药低浓度组、维拉帕米组大鼠血清vWF均低于模型组,差异有统计学意义(均P<0.05)。结论:化痰祛瘀方可使房颤痰浊血瘀证大鼠房颤持续时间缩短,延缓心房肌细胞纤维化,降低血清中VCAM-1、vWF浓度,对血管内皮细胞有保护作用。
Abstract:
Objective:To investigate therapeutic effects of Huatan Quyu formula on atrial fibrillation rats and effects on serum levels of vascular cell adhesion molecule-1(VCAM-1)and vascular hemophilia factor(vWF).Methods:60 male SD rats were randomly divided.The rats were fed with high-fat diet and injected with acetylcholine calcium chloride mixture to prepare model of atrial fibrillation with phlegm and blood stasis.After 7 days of modeling,Huatan Quyu formula was given intragastric administration for 2 weeks.Changes in duration of atrial fibrillation,ultrastructure of atrial myocytes serum VCAM-1 and vWF were observed under transmission electron microscope.Results:The duration of atrial fibrillation were shorter in the high concentration group,the medium concentration group,the low concentration group and the verapamil group than that in the model group,difference statistically significant(all P<0.05).In the model group atrial myocytes myocytes were broken,myofilaments of cardiac myocytes lysed and broken,mitochondria swollen and increased,cristae broken and dissolved,and there were vacuolar-like changes.In the medium concentration group,the myocytes were relatively intact,myofilaments slightly blurred,mitochondria swollen,mitochondria occasionally dissolved,and the structure was relatively intact.Compared with the model group,the serum VCAM-1 concentration of rats in the high concentration group and the medium concentration group decreased,difference statistically significant(all P<0.05).Compared with the model group,the serum vWF concentration of rats in the high concentration group,the medium concentration group,the low concentration group and the verapamil group were decreased,difference statistically significant(all P<0.05).Conclusion:Huatan Quyu formula can shorten the duration of atrial fibrillation,delay atrial myocyte fibrosis,reduce serum VCAM-1 and vWF concentration and protect vascular endothelial cells in rats with atrial fibrillation of Tanzhuo Xueyu syndrome.

参考文献/References:

[1] 崔景润.非瓣膜性房颤患者中医证型分布特点与Hcy的相关性研究[D].北京:北京中医药大学,2017.
[2] 张新超.老年房颤合并ACS或PCI患者的抗栓治疗[J].中国急救医学,2021,41(11):921-992.
[3] Van DR,Chung MK.Inflammasome activation and atrial fibrillation[J].Circulation,2018,138(20):2243-2246.
[4] Yao CX,Veleva T,Scott L,et al.Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation[J].Circulation,2018,138(20):2227-2242.
[5] Gurrapu A,Jukanti R,Bobbala SR,et al.Improved oral deliv-ery of valsartan from maltodextrin based proniosome powders[J].Advanced Powder Technology,2012,23(5):583-590.
[6] 陈春林,巩甜甜,汤依群,等.SD大鼠房颤模型的建立[J].实验动物科学,2009,26(3):1-4.
[7] 徐叔云,卞如濂,陈 修.药理实验方法学[M].北京:人民卫生出版社,2002:188-202.
[8] 柏 隆,张军茹.左升右降理论在心悸治疗中的应用探讨[J].陕西中医,2022,43(3):345-347.
[9] 李世樱,杨玲英,张栋梅,等.miR-499-5p靶向调控钙通道电压依赖性β-1蛋白在慢性心房颤动、心房重构中的作用研究[J].陕西医学杂志,2021,50(4):403-408.
[10] Suzuki J,Izawa A,Isobe M.Anti-vascular cell adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies inhibit neointimal hyperplasia in the murine model of arterial injury[J].Acta Cardiologica,2004,59(2):27-38.
[11] Yung HC,Shing JL,Hung HK,et al.Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-α treated human aortic endothelial cells[J].Journal of Cellular Biochemistry,2001,82(3):94-100.
[12] 李 佳,富 路,高倩萍,等.非瓣膜病性房颤患者血清VCAM-1水平及电复律的影响[J].中国老年学杂志,2006,26(2):152-153.
[13] 葛卫力,米亚非,朱 敏,等.老年心房颤动患者外周血血管性血友病因子、E-选择素、细胞间黏附分子-1和血管细胞间黏附分子-1的水平变化[J].中国老年学杂志,2017,37(21):5297-5299.
[14] 吴 峻,孙 明,周宏研,等.血管内皮生长因子与细胞黏附分子-1的表达及其对血管内皮功能的影响[J].中华老年医学杂志,2007,26(9):689-692.
[15] 白 玉,李 晋,王 璐,等.核因子-κB与血管细胞间黏附分子-1在人冠状动脉粥样硬化斑块中的表达及其与斑块稳定性的关系[J].新乡医学院学报,2010,27(2):144-147.
[16] 陈 华,罗心平,丁建平.血管性血友病因子在心血管疾病中的研究进展[J].心血管病学进展,2010,31(2):229-232.
[17] 唐秋月,梁国强,陈 伟,等.调脂颗粒对房颤大鼠血栓前标志物DD和vWF的影响研究[J].现代医药卫生,2017,33(9):1295-1298.
[18] Marin F,Roldan V,Climent VE,et al.Plasma von willebrand factor soluble thrombomodulin and fibrin D-dimer concentrations in acute onset nonrheumatic atrial fibrillation[J].Heart,2004,90(10):1162-1166.
[19] Kumagai K,Fukuchi M,Ohta J,et al.Expression of the von willebrand factor in atrial endocardium is increased in atrial fibrillation depending on the extent of structural remodeling[J].Circ Journal,2004,68(4):321-327.
[20] 曾 靖,蔡海荣,赵 帅,等.疏肝温胆汤治疗动脉粥样硬化疗效分析[J].现代中西医结合杂志,2021,30(26):2856-2860.
[21] 黄敬群.桂皮醛抗血栓和抗肿瘤作用的体内研究[D].西安:第四军医大学,2006.
[22] 佟 颖,杜武勋,李 悦,等.桂枝甘草龙骨牡蛎汤抗心律失常作用研究进展[J].吉林中医药,2015,35(5):537-540.
[23] 陈育群,张鹏飞,黄政德.桂枝甘草龙骨牡蛎汤治疗心律失常疗效及安全性的系统评价[J].中医药导报,2018,24(10):113-116,120.
[24] 谢世荣,黄彩云,杨静娴,等.甘草黄酮抗实验性心律失常的作用[J].基础医学与临床,1998,18(2):152-154.
[25] 张明发,沈雅琴.甘草酸类和甘草黄酮类化合物对心脏保护作用的研究进展[J].现代药物与临床,2012,27(4):429-434.
[26] 郝晓元,苏 云,彭延古.僵蚕注射液对凝血酶诱导血管内皮细胞纤溶平衡的影响[J].中国中西医结合急救杂志,2007,14(2):70-72.
[27] 彭延古,李露丹,邓奕辉.僵蚕抗实验性静脉血栓及作用机理的研究[J].血栓与止血学,2001,7(3):104-105.
[28] 陈凤江,郭云辉,王兴岩.白僵蚕粗提物对黑素瘤细胞与角质形成细胞共培养模型TYR及其相关蛋白TRP-1、TRP-2 mRNA表达的影响[J].中国中医药科技,2013,20(6):579.
[29] 马 竞,王小东,闫 雪,等.氧化苦参碱对脂肪间充质干细胞移植治疗急性心肌梗死大鼠心肌修复的影响[J].饮食保健,2020,6(43):67.
[30] 刘元伟,郭继鸿,张 萍,等.稳心颗粒甘松提取物对大鼠心室肌细胞钠电流和瞬时外向钾电流激活动力学的影响[J].中国心脏起搏与心电生理杂志,2009,23(6):533-535.
[31] Audrey B,Melissa N,Pierre M.IL-17 in chronic inflammation:From discovery to targeting[J].Trends in Molecular Medicine,2016,22(3):230-241.
[32] 吴丹丹,陈 瑜,张 腾.三七总皂苷对氯化钙-乙酰胆碱诱导大鼠房颤的干预效应机制[J].中华中医药杂志,2019,34(5):1938-1943.
[33] 陈姗姗,吴泽彬,张小敏,等.三七总皂苷通过调节TLR4/TLR2-NF-κB信号通路对再生障碍性贫血小鼠骨髓造血功能的影响[J].中国药理学通报,2022,38(7):1052-1058.
[34] 贾壮壮,袁 庆,陈红阳,等.丹参多酚酸配伍三七总皂苷通过调节PI3K/AKT信号通路对大鼠脑缺血/再灌注损伤神经元凋亡的影响[J].中国药理学通报,2020,36(9):1214-1220.
[35] 范彦芳,李前宽,周晓慧,等.丹皮酚、三七总皂苷联合应用对心梗后心室重构大鼠心肌组织NF-κBp65、TNF-α表达的影响[J].承德医学院学报,2017,34(4):271-273.
[36] 孙红丹,聂 丹,周晓慧,等.丹皮酚联合三七总皂苷对Ang-Ⅱ诱导的心脏成纤维细胞增殖及TGF-β/Smads信号通路的影响[J].中成药,2016,38(4):729-735.
[37] 王 茹,王培利,王承龙.房颤的中医研究进展[J].辽宁中医杂志,2020,47(6):213-216.
[38] 顾杨洪,张彩英,黄桂秋,等.丹参和丹参素对牛内皮细胞抗凝和纤溶功能的影响[J].上海第二医科大学学报,1990,10(3):208-212.
[39] 王辰晖,董 志.丹参酮ⅡA与瑞舒伐他汀联合对冠状动脉粥样硬化性心脏病合并颈动脉粥样硬化患者的疗效及对趋化素、p38-MAPK及核因子κB的影响[J].中国药物经济学,2021,16(10):105-108.
[40] 曾胜煌,何长国,王 越,等.葛根素注射液联合丹参酮ⅡA磺酸钠治疗慢性充血性心力衰竭患者的疗效及对血浆血浆肾素活性和醛固酮的影响[J].世界中医药,2019,14(7):1809-1812.

相似文献/References:

[1]渠 乐,周 云,沈宝藩.养心汤治疗气阴两虚、心血瘀阻型心悸临床研究*[J].陕西中医,2020,(10):1396.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.015]
　QU Le,ZHOU Yun,SHEN Baofan..Study on the application of Yangxin decoction in treating palpitation of Qi-Yin deficiency and heart blood stasis type[J].,2020,(9):1396.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.015]
[2]冉俊宁,陈朝阳,冯 君,等.基于网络药理学探讨生脉散治疗快速性心律失常气阴两虚证作用机制[J].陕西中医,2021,(3):383.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.031]
　RAN Junning,CHEN Zhaoyang,FENG Jun,et al.Research on mechanism of Shengmaisan in treating tachyarrhythmia with Qiyin Liangxu based on network pharmacology[J].,2021,(9):383.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.031]
[3]李 苗,张 妍,雷瑗琳.心脾同治在慢性心力衰竭治疗中的应用进展[J].陕西中医,2021,(6):814.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.035]
[4]王 辉,袁 捷,韩祖成,等.基于平衡TF/TFPI水平研究三七在心房颤动大鼠治疗中维持抗凝/出血稳态的作用及机制[J].陕西中医,2021,(11):1522.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.006]
　WANG Hui,YUAN Jie,HAN Zucheng,et al.Effect and mechanism of Panax notoginseng on maintaining anticoagulation/bleeding homeostasis in rats with atrial fibrillation based on balanced TF/TFPI levels[J].,2021,(9):1522.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.006]
[5]陈 勇,王 洁,杨 彤,等.心衰病中西医研究进展[J].陕西中医,2022,(1):134.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.035]
[6]周 媛,李启注,徐京育.苓桂术甘汤治疗心力衰竭研究进展[J].陕西中医,2022,(12):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]
　ZHOU Yuan,LI Qizhu,XU Jingyu.Overview of the clinical application of Linggui Zhugan prescription in the treatment of heart failure[J].,2022,(9):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]
[7]张 芹,周思远,刘如秀.名中医刘如秀从肾论治新型冠状病毒感染后心律失常经验[J].陕西中医,2023,(11):1606.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.027]

备注/Memo

备注/Memo:
基金项目:辽宁省科学技术基金资助项目(20180530016); 辽宁省特聘教授课题(21601A1088)
更新日期/Last Update: 2022-09-08